Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

Research from a collaborative team of biomedical engineers, physicians and scientists could enable significant advances for the 40,000 pediatric congenital heart disease patients (CHD) born each year.

The Christ Hospital Heart & Vascular Institute has announced the use of HeartFlow in a diagnostic coronary CT angiogram, a first for the region. Heartflow is “a sophisticated and predictive analytics ...

Researchers at the University of East Anglia have developed cutting-edge imaging technology to help doctors better diagnose and monitor patients with heart failure. The state-of-the-art technology ...

HeartFlow (NASDAQ: HTFL) had a Thursday to remember, at least as far as its stock was concerned. The specialty healthcare company saw its share price leap by 9% that day, on news that its technology ...

HeartFlow's market-moving announcement was that the U.S. Food and Drug Administration (FDA) granted approval for its HeartFlow Plaque Analysis algorithm. Following that, the company said the product ...